Neurology Minute

Neurology Minute

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(1945)

Oligoclonal bands and differentiation

Oligoclonal bands and differentiation

Dr. Rae Bacharach discusses oligoclonal bands in MS and other conditions and differentiating types of bands.

31 Heinä 20191min

CDC's Guideline on Pediatric Mild Traumatic Brain Injury: Recommendations for Neurologists

CDC's Guideline on Pediatric Mild Traumatic Brain Injury: Recommendations for Neurologists

Dr. Barbara Weissman discusses the main points from her Neurology: Clinical Practice paper on recommendations for neurologists on the CDC's Guideline on Pediatric Mild Traumatic Brain Injury.

30 Heinä 20191min

Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke

Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke

Dr. Geoffrey Donnan discusses the main takeaways from his study on thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. Read his NEJM article here: https://www.nejm.org/doi/pd...

29 Heinä 20192min

Continuum Pearls: Disease-Modifying Therapies in MS

Continuum Pearls: Disease-Modifying Therapies in MS

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the third part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Diseas...

25 Heinä 20191min

Continuum Pearls: Disease-Modifying Therapies in MS, pt. 2

Continuum Pearls: Disease-Modifying Therapies in MS, pt. 2

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the second part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disea...

24 Heinä 20193min

Determining clinically meaningful decline in preclinical Alzheimer disease

Determining clinically meaningful decline in preclinical Alzheimer disease

Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease.

23 Heinä 20191min

Targeting Huntington Expression in Patients with Huntington's Disease

Targeting Huntington Expression in Patients with Huntington's Disease

Dr. Sarah Tabrizi discusses the main findings of her study on targeting Huntington expression in patients with Huntington's Disease. Ready the May 6th article in NEJM: https://www.nejm.org/doi/full/10...

22 Heinä 20191min

Continuum Pearls: Disease-Modifying Therapies in MS

Continuum Pearls: Disease-Modifying Therapies in MS

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the first part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Diseas...

19 Heinä 20192min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
rss-pitaisko-erota
vakeva-elama-viisaampi-mieli-vahvempi-keho
psykopodiaa-podcast
tiedenaiset-podcast
terapiassa
voi-hyvin-meditaatiot-2
rss-kuumilla-aalloilla
selviytyjat-tarinoita-elamasta
rss-narsisti
meditaatiot-suomeksi
rss-pt-paahtio
rss-nautinto
katilon-kahvitunti
rss-rakas-mielenterveyteni
rss-hereilla
rss-uplevel-by-sonja-hannus
junnut-pelissa
fitnessvastaanotto
herkka-mut-rohkee